We are live on ! Find out more
WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$310M
AUM Growth
-$281M
Cap. Flow
-$263M
Cap. Flow %
-84.79%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
3
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AUTL
Autolus Therapeutics
AUTL
+$126M
2
PRTA icon
Prothena Corp
PRTA
+$92.7M
3
NCNA
NuCana
NCNA
+$22M
4
TBPH icon
Theravance Biopharma
TBPH
+$16.4M
5
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
+$6.34M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBPH icon
1
Theravance Biopharma
TBPH
$885M
$221M 71.3%
11,350,719
-809,261
-7% -$16.4M
EVFM
2
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$63M 20.31%
833,081
-82,508
-9% -$6.34M
AUTL
3
Autolus Therapeutics
AUTL
$623M
$26M 8.39%
2,095,127
-9,499,107
-82% -$126M
NCNA
4
NuCana
NCNA
$7.33M
– –
-424
Closed -$22M
PRTA icon
5
Prothena Corp
PRTA
$479M
– –
-8,773,790
Closed -$92.7M

Similar funds

LCM
Lucha Capital Management San Francisco, California $327M AUM 2.87% 1-Year Est. Return
GWA
Guidant Wealth Advisors Palatine, Illinois $269M AUM 0.85% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
AEPG
American Economic Planning Group Warren, New Jersey $367M AUM 2.51% 1-Year Est. Return
AR
Argyll Research Wilmington, Delaware $377M AUM 4.86% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
COI
Capital One Investing Mclean, Virginia $430M AUM 3.49% 1-Year Est. Return

Woodford Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Woodford Investment Management held 5 positions worth $310M, down 48% from $591M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Woodford Investment Management withdrew a net $263M in Q3 2019, closing 2 positions and reducing 3 holdings. Its most notable exit was Prothena Corp, an estimated $92.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Woodford Investment Management's biggest Q3 2019 reduction was Autolus Therapeutics, cutting an estimated $126M.
  • Woodford Investment Management fully exited Prothena Corp in Q3 2019, selling an estimated $92.7M.
  • Woodford Investment Management's ten largest holdings make up 100% of its $310M portfolio in Q3 2019.
  • Woodford Investment Management opened 0 new positions and closed 2 in Q3 2019.
  • Woodford Investment Management's portfolio value fell 48% quarter-over-quarter to $310M.

Based on Woodford Investment Management's 13F filing for Q3 2019, filed 8 Nov 2019.